These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31092343)

  • 41. Limited revision of fee schedules--NRC. Final rule.
    Fed Regist; 1992 Apr; 57(75):13625-34. PubMed ID: 10118460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear medicine affected by Energy Policy Act of 2005.
    J Nucl Med; 2005 Oct; 46(10):12N, 14N. PubMed ID: 16312055
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiation dose produced by patients during radiopharmaceutical incorporation in nuclear medicine diagnostic procedures.
    Morán V; Prieto E; García-García B; Barbés B; Ribelles MJ; Richter JÁ; Martí-Climent JM
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):175-85. PubMed ID: 26750552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NRC proposes ruling on patient release, Agreement States.
    Miller L
    J Nucl Med; 1994 Sep; 35(9):22N-23N. PubMed ID: 8071717
    [No Abstract]   [Full Text] [Related]  

  • 45. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality management program and misadministrations--Nuclear Regulatory Commission. Final rule.
    Fed Regist; 1991 Jul; 56(143):34104-22. PubMed ID: 10112867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The current NRC definitions of therapy misadministration are vague, do not reflect the norms of clinical practice, and should be rewritten. For the proposition.
    Amols H
    Med Phys; 2004 Apr; 31(4):691-3. PubMed ID: 15124984
    [No Abstract]   [Full Text] [Related]  

  • 48. Institute of Medicine study supports state regulation of medical isotopes over NRC.
    Silver S
    J Nucl Med; 1996 Feb; 37(2):23N. PubMed ID: 8667050
    [No Abstract]   [Full Text] [Related]  

  • 49. The current NRC definitions of therapy misadministration are vague, do not reflect the norms of clinical practice, and should be rewritten. Against the proposition.
    Williamson JF
    Med Phys; 2004 Apr; 31(4):693-4. PubMed ID: 15124985
    [No Abstract]   [Full Text] [Related]  

  • 50. NRC's ACMUI (Advisory Committee on the Medical Uses of Isotopes) meets for first time in two years.
    Ghosh PR
    J Nucl Med; 1990 Oct; 31(10):23A, 24A, 26A. PubMed ID: 2213205
    [No Abstract]   [Full Text] [Related]  

  • 51. ACNP/SNM Government Relations Office midyear report: January-May 1998. American College of Nuclear Physicians/Society of Nuclear Medicine.
    Nichols D
    J Nucl Med; 1998 Jun; 39(6):24N-25N. PubMed ID: 9627320
    [No Abstract]   [Full Text] [Related]  

  • 52. Nuclear Regulatory Commission revises medical policy statement.
    J Nucl Med; 2000 Oct; 41(10):9N. PubMed ID: 11037983
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulatory controls over the medical use of radioisotopes.
    Podolak E
    J Clin Eng; 1978; 3(2):145-52. PubMed ID: 10308310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congress puts pressure on NRC.
    Nichols D
    J Nucl Med; 1996 Nov; 37(11):44N. PubMed ID: 8917167
    [No Abstract]   [Full Text] [Related]  

  • 55. SNM/ACNP petition NRC to change 10 CFR 35.
    J Nucl Med; 1989 Aug; 30(8):1296. PubMed ID: 2754486
    [No Abstract]   [Full Text] [Related]  

  • 56. The radiopharmaceutical industry and European Union regulations.
    Fallais CJ; Sivewright S; Ogle JR
    Eur J Nucl Med; 1997 Jan; 24(1):77-9. PubMed ID: 9044882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The AAPM should develop protocols generically, and avoid documents that are too strict and prescriptive, to facilitate their adoption by regulatory agencies like the Nuclear Regulatory Commission and States.
    Jones CG; Thomadsen B
    Med Phys; 2000 Mar; 27(3):431-3. PubMed ID: 10757592
    [No Abstract]   [Full Text] [Related]  

  • 58. [The nuclear medicine specialist, expert in radiopharmacology. A long and winding road].
    Freire J; Banzo J; Martín-Comín J
    Rev Esp Med Nucl; 2001 Dec; 20(7):515-6. PubMed ID: 11709135
    [No Abstract]   [Full Text] [Related]  

  • 59. Nuclear Regulatory Commission regulatory status of approved intravascular brachytherapy systems.
    Glasgow GP;
    Cardiovasc Radiat Med; 2002; 3(1):60-6. PubMed ID: 12479918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NRC Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive.
    J Nucl Med; 2019 Jul; 60(7):9N. PubMed ID: 31263088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.